Retina Program Overview

CME INFORMATION

RETINA PROGRAM

Evaluations and CME Certificates

This year's evaluations are available HERE through February 21, 2023 (your username is your email and the password is "Hawaii"). Please email evals@HealioLive.com if you need assistance with this year’s credits or cme@VindicoMedEd.com if you need a certificate from a previous year.

Target Audience

The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with retinal disease.

Program Summary

This program is designed by and for retina specialists, offering updates on the most recent advances and their integration into everyday practice as well as insight into varying challenges, including the implementation of new diagnostic and treatment modalities. In a relaxed setting, faculty and attendees can discuss specific cases, new therapy and imaging technologies and the latest surgical strategies. This program offers a non-concurrent schedule including: Breakfast programs, general sessions, exhibit breaks, lunch programs, workshops, banyan tree sessions and special events (all included in the single registration fee except the luau). Retina Program attendees are also able to attend sessions of interest under the Hawaiian Eye Comprehensive Ophthalmologist Program.

Learning Objectives: General Sessions (Monday to Friday)

Upon completion of this activity, attendees will have better knowledge of the following subject matters:

Detail updates in imaging and new technologies, their use in evaluation and prognosis, and OCT findings and predictors in specific retinal diseases and conditions.
Discuss abstract presentations on medical and surgical advances, as well as real-world findings that can improve retinal disease management.
Assess the safety, efficacy, and use of new treatments in the management of age-related macular degeneration.
Summarize the latest information about the management of macular degeneration, the use of drug delivery, gene therapy, as well as the treatment of geographic atrophy.
Explore new insights on the management of diabetic eye disease including DRCR Retina Network trial data, the use of artificial intelligence, and retinal detachment repair.
Examine management strategies for retinal vascular diseases including the detection of paracentral acute middle maculopathy, as well as the imaging and treatment of retinal vein occlusion.
Review the utility of multi-modal imaging, use of anti-VEGF, and treatment of uveitis in pediatric patients.
Describe current management strategies for uveitis, as well as for ocular tumors.
Explore insights and practical considerations in the management of inherited retinal diseases, the use of gene and cell therapy, and optogenetic strategies for restoring vision.
Assess techniques and technology that can improve retinal surgery outcomes including the management of diabetic retinopathy, floaters, retinal detachment, macular hole, as well as the use of 3D surgical systems.
Examine best practices and clinical pearls for managing challenging retinal disorder case presentations.

This continuing education activity is provided by

ACCREDITATION: In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 26.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INTERNATIONAL NOTICE: This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. US physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.

FACULTY/PLANNER DISCLOSURE POLICY: Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational uses of any products/devices.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.